New pain drug TT5 enters first human tests – could it ease Post-Surgery pain?
NCT ID NCT06789861
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a new drug, TT5, for pain relief. It involves 94 healthy adults and surgical patients to check safety and how the drug moves through the body. Participants receive either TT5 or a placebo, and researchers monitor side effects and vital signs. The goal is to find safe doses for future studies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cmax & PARC
RECRUITINGAdelaide, South Australia, 5000, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Electric pulses on the wrist may tame colonoscopy pain
- Virtual reality may distract patients from pain and fear during anesthesia
- Could a gentle yoga practice turn down the Body's pain and inflammation?
- Can a 5-Pill opioid prescription match a 30-Pill one after hip surgery?
- Parkinson's pain: could a new Add-On drug bring relief?